Wikipedia -WSS

Wikipedia

author：Wikipedia 2025-10-01 00:49:11 - browse：4

Adam's take main illustration — Molly Ferguson/STAT

Have you heard the news? I’m launching a weekly email newsletter starting on March 28. It’s called Adam’s Biotech Scorecard and it’s exclusively for STAT subscribers. One catch: We need you to sign up, which you can do here. What should you expect to see in my newsletter each week? Unfiltered, uncompromising, and (hopefully) valuable insight and analysis from the intersection of Wall Street and biotech. Plus, a few dashes of fun.

This week: A chat with Argenx CEO Tim Van Hauwermeiren, and updates on biotech PIPEs, Madrigal Pharmaceuticals, and Annovis Bio.

The Belgian drugmaker Argenx is preparing for a commercial launch this summer that will expand the use of its IgG-lowering antibody Vyvgart to patients with chronic inflammatory demyelinating polyneuropathy, or CIDP, an autoimmune nerve disorder that causes people to lose feeling and muscle strength in the arms and legs.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Gene therapies for deafness raise the question: Do deaf people want a 'cure'?

Wikipedia

WSS

Addiction doctors spar with methadone clinics over legislation

Designating disabled people as health disparity population is crucial

What will save rural psychiatry services? Higher Medicaid payments

Focused ultrasound for uterine fibroids: an uphill battle

How I ended up pumping milk in a bathroom stall at JPM 2024

iTeos Therapeutics debuts first data on TIGIT

hotspot

Wikipedia

leisure time

Supreme Court strikes down use of affirmative action

Readout LOUD podcast: FTC v. biotech, future of Pfizer and Vertex

Supreme Court strikes down use of affirmative action

David Sabatini, ex

Affirmative action in medical school literally saved lives

FDA’s Peter Marks seems inclined to back Sarepta’s gene therapy

DIEP, the 'gold standard' of breast reconstruction, is under threat

Doudna institute plans to 'cure hundreds of diseases' with CRISPR

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Focused ultrasound for uterine fibroids: an uphill battle

focus

Do more moles mean more problems? Not so, says new study

Merus drug and Keytruda shrank tumors in patients with head and neck cancer

Biotech reporter’s notebook: A sunnier mood at JPM 2024

Doudna institute plans to 'cure hundreds of diseases' with CRISPR

Fauci’s Covid grilling leads GOP to weigh foreign research rules

iTeos Therapeutics debuts first data on TIGIT

explore

Wikipedia

hotspot

hotspot